Kirsten Lawson summarises a new 'state of the art review' in the BMJ which focuses on novel and emerging pharmacotherapy and neuromodulation for people with 'treatment resistant depression'.
The post New and emerging treatments for major depressive disorder appeared first on National Elf Service.